PharmaEssentia Corporation reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 1,653.44 million compared to TWD 887.65 million a year ago. Net income was TWD 330.39 million compared to net loss of TWD 735.54 million a year ago.

Basic earnings per share from continuing operations was TWD 1 compared to basic loss per share from continuing operations of TWD 2.44 a year ago. Diluted earnings per share from continuing operations was TWD 0.99 compared to diluted loss per share from continuing operations of TWD 2.44 a year ago.